BMRN vs IBO · P/E 40, rev $1.76B vs rev $10.0K
Biomarin Pharmaceutical Inc (BMRN) versus Impact BioMedical, Inc. (IBO) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Impact BioMedical, Inc. (IBO) is a biotechnology company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported IBO revenue for 2026-06-30 was $10.0K. Net income was -$3.0M. Revenue was up 42.9% from 2026-03-31 to 2026-06-30. IBO currently screens at market cap $7.6M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. IBO currently screens at market cap $7.6M.
Not investment advice. Open the BMRN and IBO stock pages for the full models.
Not investment advice.